Targeted vitamin D3 therapy shown to cut second heart attack risk by 50% in groundbreaking trial
In a healthcare system dependent on expensive, patent-protected drugs, a new clinical breakthrough offers a stunning rebuke: a simple, affordable vitamin, when used correctly, can dramatically alter the grim statistics of heart disease. Presented at the 2025 American Heart Association Scientific Sessions, research from Intermountain Health reveals that a personalized “target to treat” strategy with vitamin D3 slashes the risk of a recurrent heart attack by approximately half.
Read Full Article: https://www.naturalnews.com/2026-04-22-targeted-vitamin-d3-therapy-shown-to-cut-second-heart-attack-risk-by-50-percent.html
